The role of the technological service sector in medical drugs manufacture by Virion

Бесплатный доступ

This paper shows the development of the Scientific Industrial Company for Immunobiological Medicines Virion over the period from 2000 to 2010. It reveals the aspects of increasing the drugs efficiency through improving their quality and lowering cost price and registering newly emerging drugs and re-registering already existing ones.

Technological department, стандарты gmp, gmp standards, rate of raw materials consumption, technical and economical performance, registration of medical drugs

Короткий адрес: https://sciup.org/14919469

IDR: 14919469

Статья научная